Related Experiment Video
Updated: Jun 21, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
The road not taken: a path to curing type 1 diabetes?
Michael J Haller1, Mark A Atkinson, Desmond A Schatz
1Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA. hallemj@peds.ufl.edu
European Journal of Immunology
|August 13, 2009
Summary
Despite advances in understanding autoimmune type 1 diabetes, preventing or reversing the disease remains elusive. This review examines current management controversies and challenges in translating research for better type 1 diabetes treatment strategies.
Area of Science:
- Immunology
- Endocrinology
- Autoimmune Diseases
Background:
- Significant progress in understanding the natural history of autoimmune type 1 diabetes over the last 25 years.
- Current therapeutic strategies remain insufficient for preventing or reversing type 1 diabetes.
- Existing knowledge has not translated into effective clinical interventions.
Purpose of the Study:
- To discuss controversies in the current management of type 1 diabetes.
- To highlight challenges in translating findings from animal models to human subjects.
- To explore obstacles in designing effective prevention and intervention studies for type 1 diabetes.
Main Methods:
- Literature review and critical analysis of current research.
- Discussion of translational challenges from preclinical (mouse models) to clinical settings.
- Examination of hurdles in the design of human prevention and intervention trials.
Main Results:
- Identification of key controversies in type 1 diabetes management.
- Analysis of the gap between promising preclinical results and human clinical efficacy.
- Recognition of significant challenges in developing robust study designs for prevention and intervention.
Conclusions:
- There is a critical need to address management controversies and translational barriers.
- Novel strategies are required to overcome obstacles in type 1 diabetes research and clinical application.
- Future research must focus on improving the design and execution of prevention and intervention studies to achieve therapeutic success.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...